Sofosbuvir and Daclatasvir Anti–Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient

Gastroenterology

Volumn 152, Issue 1, 2017, Pages 300-301

  Donnelly, Mhairi C ^a   Imlach, Stuart N ^b   Abravanel, Florence ^c   Ramalingam, Sandeep ^a   Johannessen, Ingolfur ^a   Petrik, Juraj ^b   Fraser, Alistair R ^b   Campbell, John D M ^b   Bramley, Peter ^d   Dalton, Harry R ^e   Hayes, Peter C ^a   Kamar, Nassim ^f   Simpson, Kenneth J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c CHU PURPAN   (France)

^d Forth Valley Royal ^*  (United Kingdom)

^e UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^f CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DACLATASVIR; GAMMA INTERFERON; INTERLEUKIN 2; RIBAVIRIN; SOFOSBUVIR; TUMOR NECROSIS FACTOR; ANTIVIRUS AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOREACTIVE T CELL; ANTIVIRAL THERAPY; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CHRONIC HEPATITIS C; CYTOKINE RESPONSE; DRUG TREATMENT FAILURE; EFFECTOR CELL; GRAFT INFECTION; GRAFT RECIPIENT; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; LETTER; LIVER GRAFT; MEMORY T LYMPHOCYTE; MIXED INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PRIORITY JOURNAL; VIREMIA; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; T LYMPHOCYTE;

ANTIVIRAL AGENTS; COINFECTION; HEPATITIS C; HIV INFECTIONS; HUMANS; SOFOSBUVIR; T-LYMPHOCYTES; VIREMIA;

EID: 85006277752     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.05.060     Document Type: Letter

References (3)

1. 1 Dao Thi, V.L., et al. Gastroenterology 150 (2016), 82–85.
2. 2 Suneetha, P.V., et al. Hepatology 55 (2012), 695–708.
3. 3 Burchill, M.A., et al. J Viral Hepatol 22 (2015), 983–991.